|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
09-14-2010, 09:25 PM
|
|||
|
|||
Bone-Loss Drugs Linked to Higher Risk of Uncommon Thigh Break, Report Says
Drugs to prevent bone loss, including Merck & Co.’s Fosamax, Roche Holding AG’s Boniva, and Novartis AG’s Reclast, may be linked to an increased risk of fractures to the thigh bone, researchers said.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Panel Recommends Thigh Fracture Warning for Bone Drugs | cancerfr | Bone Cancer | 0 | 09-14-2010 09:25 PM |
| Common bone drugs linked to esophageal cancer risk | cancerfr | Bone Cancer | 0 | 09-03-2010 07:26 AM |
| Bone drugs linked to cancer risk | cancerfr | Bone Cancer | 0 | 09-03-2010 07:26 AM |
| Drugs used to treat osteoporosis not linked with higher risk of esophageal cancer | cancerfr | Oral Cancer | 0 | 09-03-2010 07:26 AM |
| Drugs used to treat osteoporosis not linked with higher risk of esophageal cancer | cancerfr | Oral Cancer | 0 | 08-11-2010 10:47 AM |
Linear Mode
